Tone mix
Week by week 52 weeks
Share of Bio-Techne Corp.'s 189 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 5, 2026 · tone +100Bio-Techne opens GMP small molecule facility in Bristol, UK+82
- Week of Oct 27, 2025 · tone +98Bio-Techne Launches ProximityScope Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research+77
- Week of Apr 6, 2026 · tone -37Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Stock-70
- Week of Jan 26, 2026 · tone +100Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Analysts+67
- Week of Feb 16, 2026 · tone +100Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU+62
- Week of Sep 8, 2025 · tone -50Why Bio-Techne (TECH) Stock Is Down Today | FinancialContent-61
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Bio-Techne Corp. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 8 | +43 |
| Last 90 sessions | 66 | +44 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 12, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletBio-Techne Corp (NASDAQ:TECH) Stock Has Consensus Price Target of $68.92Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Bio-Techne Corp (NASDAQ:TECH) Stock Has Consensus Price Target of $68.92 | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.pharmaceutical-business-review.com · 1 outletBio-Techne opens GMP small molecule facility in Bristol, UKPositive
- www.news-medical.net · 1 outletBio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy developmentPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Bio-Techne opens GMP small molecule facility in Bristol, UK | www.pharmaceutical-business-review.com | 1 | Positive |
| Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development | www.news-medical.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, September 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletBio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay PackageNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package | www.insidermonkey.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, September 24, 2026
2 headlines, average tone +73: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 2 outletsBio-Techne Shareholders Approve Merck KGaA Acquisition PlanPositive
- www.prnewswire.com · 1 outletBio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Bio-Techne Shareholders Approve Merck KGaA Acquisition Plan | www.rttnews.com | 2 | Positive |
| Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany | www.prnewswire.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 23, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletFinancial Contrast: Bio-Techne (NASDAQ:TECH) & Pacific Biosciences of California (NASDAQ:PACB)Neutral
- www.themarketsdaily.com · 1 outletHead-To-Head Survey: VivoSim Labs (NASDAQ:VIVS) versus Bio-Techne (NASDAQ:TECH)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Contrast: Bio-Techne (NASDAQ:TECH) & Pacific Biosciences of California (NASDAQ:PACB) | www.themarketsdaily.com | 1 | Neutral |
| Head-To-Head Survey: VivoSim Labs (NASDAQ:VIVS) versus Bio-Techne (NASDAQ:TECH) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Bio-Techne Corp., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.